![]() |
![]() | ![]() |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
CITA Biomedical, Inc. ( OTCBB: DTOX ), is the publicly traded parent company of the wholly owned subsidiaries, CITA Americas, Inc. and AltTPro Inc.. Established in 1998, CITA is a leading supplier of neural recovery and detoxification solutions for the United States chemical dependence/addiction market. CITA recognizes the need for safe, cost effective, and clinically recognized treatments for the disease of addiction. Website: citabio.com | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |